Found: 14
Select item for more details and to access through your institution.
GPS precise point positioning for UAV photogrammetry.
- Published in:
- Photogrammetric Record, 2018, v. 33, n. 164, p. 427, doi. 10.1111/phor.12259
- By:
- Publication type:
- Article
Lu AE58054, a 5-HT<sub>6</sub> antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats.
- Published in:
- International Journal of Neuropsychopharmacology, 2010, v. 13, n. 8, p. 1021, doi. 10.1017/S1461145710000659
- By:
- Publication type:
- Article
T109. MODULATORY ACTIVITY OF THE NOVEL DRUG SEP-363856 ON BRAIN FUNCTION: POTENTIAL APPLICATION FOR THE TREATMENT OF SCHIZOPHRENIA.
- Published in:
- Schizophrenia Bulletin, 2019, v. 45, p. S246, doi. 10.1093/schbul/sbz019.389
- By:
- Publication type:
- Article
Towards Novel Treatments for Schizophrenia: Molecular and Behavioural Signatures of the Psychotropic Agent SEP-363856.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 8, p. 4119, doi. 10.3390/ijms22084119
- By:
- Publication type:
- Article
Aerobic exercise improves memory and prevents cognitive deficits of relevance to schizophrenia in an animal model.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D receptor mechanism.
- Published in:
- Psychopharmacology, 2011, v. 214, n. 4, p. 843, doi. 10.1007/s00213-010-2091-5
- By:
- Publication type:
- Article
Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT<sub>6</sub> and 5-HT<sub>2A</sub> receptor mechanisms.
- Published in:
- Psychopharmacology, 2010, v. 208, n. 1, p. 23, doi. 10.1007/s00213-009-1702-5
- By:
- Publication type:
- Article
Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors.
- Published in:
- Psychopharmacology, 2009, v. 207, n. 1, p. 119, doi. 10.1007/s00213-009-1639-8
- By:
- Publication type:
- Article
Correction to: Luvadaxistat: A Novel Potent and Selective d-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Luvadaxistat: A Novel Potent and Selective d-Amino Acid Oxidase Inhibitor Improves Cognitive and Social Deficits in Rodent Models for Schizophrenia.
- Published in:
- Neurochemical Research, 2023, v. 48, n. 10, p. 3027, doi. 10.1007/s11064-023-03956-2
- By:
- Publication type:
- Article
Oscillatory Deficits in the Sub-Chronic PCP Rat Model for Schizophrenia Are Reversed by mGlu5 Receptor-Positive Allosteric Modulators VU0409551 and VU0360172.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 6, p. 919, doi. 10.3390/cells12060919
- By:
- Publication type:
- Article
Global brain volume reductions in a sub-chronic phencyclidine animal model for schizophrenia and their relationship to recognition memory.
- Published in:
- 2019
- By:
- Publication type:
- journal article
PNU-120596, a positive allosteric modulator of α7 nicotinic acetylcholine receptors, reverses a sub-chronic phencyclidine-induced cognitive deficit in the attentional set-shifting task in female rats.
- Published in:
- Journal of Psychopharmacology, 2012, v. 26, n. 9, p. 1265, doi. 10.1177/0269881111431747
- By:
- Publication type:
- Article
PD168077, a D4 receptor agonist, reverses object recognition deficits in rats: potential role for D4 receptor mechanisms in improving cognitive dysfunction in schizophrenia.
- Published in:
- Journal of Psychopharmacology, 2011, v. 25, n. 6, p. 792, doi. 10.1177/0269881110387840
- By:
- Publication type:
- Article